New Japanese initiatives on stem cell therapies
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In September 2014, the Japanese Diet enacted laws and amendments intended to improve and simplify the regulation of regenerative medicine in Japan.
“In September 2014, the Japanese Diet, or legislature, enacted a set of laws and amendments intended to improve and simplify the regulation of regenerative medicine in Japan”
From Brief summary of the regulatory frameworks of regenerative medicine therapies (2025) · cites this paper as Konomi et al., 2015
The Abstract (page not provided) says two laws creating a new framework for regenerative medicine came into effect on November 25, 2014. The Introduction describes a revised pharmaceutical law and the aim of delivering treatments promptly while ensuring safety. Our copy does not say that the Japanese Diet enacted the laws in September 2014; the November effective date does not establish their enactment date. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Part of this paper’s reference list could not be split into single entries.
Research works printed but not linked: 4
- [1]1. Dolgin, E. Nat. Med. 2014; 20:796-797 Crossref Scopus (7) PubMed Google Scholar
- [2]2. Editorial Nature. 2013; 494:5 Google Scholar
- [3]3. Eichler, H.G. ∙ Oye, K. ∙ Baird, L.G. ... Clin. Pharmacol. Ther. 2012; 91:426-437 Crossref Scopus (221) PubMed Google Scholar
- [4]4. Hara, A. ∙ Sato, D. ∙ Sahara, Y. Therapeutic Innovation & Regulatory Science. 2014; 48:681-688 Crossref Scopus (64) Google Scholar
Cited by
Sorted by citations
Brief summary of the regulatory frameworks of regenerative medicine therapies
Yoon, J., Lee, S., Kim, M. J., & Kim, J.-H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486812 · Cited by 38 · see citing works
- Authors
- Konomi, K., Tobita, M., Kimura, K., & Sato, D.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 16
- Issue
- 4
- Pages
- 350-352
- ISSN
- 1934-5909
- Cited by
- 129
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
